Valuation: Biogen Inc.

Market Cap 29.37B 25.69B 23.69B 21.88B 41.52B 2,801B 42.22B 283B 111B 1,380B 110B 108B 4,743B P/E 2026 *
30.3x
P/E 2027 * 16.7x
Enterprise Value 34.88B 30.51B 28.14B 25.99B 49.31B 3,326B 50.14B 336B 132B 1,639B 131B 128B 5,633B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.15x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.22%
1 week-4.96%
Current month-8.31%
1 month+1.99%
3 months+14.53%
6 months+6.72%
Current year+12.57%
1 week 194.37
Extreme 194.3694
215.95
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
281.68
5 years 110.04
Extreme 110.035
358.77
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Chairman

2,005 0.0014%
09/06Fiscal year

Director

6,245 0.0042%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%-4.96%+46.39%-29.64% 29.37B
-0.86%+1.62%+17.96%-6.12% 67.96B
-5.16%-8.63%+37.37%+202.27% 54.4B
-2.10%+4.37%-49.58%-53.96% 41.74B
+5.28%+39.50%+39.50%+39.50% 40.63B
-11.57%-17.10%+97.81%-44.91% 30.38B
-1.67%+0.30%+64.87%+87.38% 23.68B
+3.88%+5.10%+9.06%+196.53% 19.15B
-4.39%+10.64%+85.91%+395.51% 17.68B
-1.59%-1.63%+61.04%+130.75% 17.14B
Average -1.79%+1.14%+41.03%+91.73% 34.21B
Weighted average by Cap. -1.84%+0.36%+33.31%+66.56%

Financials

2026 *2027 *
Net sales 10.05B 8.79B 8.11B 7.49B 14.22B 959B 14.45B 96.92B 38.06B 472B 37.75B 36.93B 1,624B 10.38B 9.08B 8.38B 7.74B 14.68B 990B 14.93B 100B 39.31B 488B 38.99B 38.14B 1,677B
Net income 1.49B 1.31B 1.21B 1.11B 2.11B 143B 2.15B 14.41B 5.66B 70.23B 5.61B 5.49B 241B 1.97B 1.72B 1.59B 1.47B 2.78B 188B 2.83B 18.98B 7.45B 92.51B 7.39B 7.23B 318B
Net Debt 5.51B 4.82B 4.44B 4.1B 7.79B 525B 7.92B 53.1B 20.85B 259B 20.68B 20.23B 890B 3.38B 2.96B 2.73B 2.52B 4.79B 323B 4.87B 32.63B 12.81B 159B 12.71B 12.43B 547B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
11/07/26 USD 199.63 +0.36% 465,266
09/07/26 USD 198.91 -0.72% 1,657,327
08/07/26 USD 200.36 -2.60% 1,947,888
07/07/26 USD 205.70 -1.32% 1,156,880
06/07/26 USD 208.46 -3.54% 1,218,492
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
198.91USD
Average target price
222.83USD
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock